These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31960161)

  • 1. Nausea and Vomiting: a Palliative Care Imperative.
    Wickham RJ
    Curr Oncol Rep; 2020 Jan; 22(1):1. PubMed ID: 31960161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : a systematic review].
    Benze G; Geyer A; Alt-Epping B; Nauck F
    Schmerz; 2012 Sep; 26(5):481-99. PubMed ID: 22983450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer.
    Glare P; Pereira G; Kristjanson LJ; Stockler M; Tattersall M
    Support Care Cancer; 2004 Jun; 12(6):432-40. PubMed ID: 15108099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].
    Benze G; Alt-Epping B; Geyer A; Nauck F
    Schmerz; 2012 Sep; 26(5):500-14. PubMed ID: 22968365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer.
    Stephenson J; Davies A
    Support Care Cancer; 2006 Apr; 14(4):348-53. PubMed ID: 16228185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating nausea and vomiting in palliative care: a review.
    Glare P; Miller J; Nikolova T; Tickoo R
    Clin Interv Aging; 2011; 6():243-59. PubMed ID: 21966219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting.
    Spitzer TR; Grunberg SM; Dicato MA
    Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer.
    Walsh D; Davis M; Ripamonti C; Bruera E; Davies A; Molassiotis A
    Support Care Cancer; 2017 Jan; 25(1):333-340. PubMed ID: 27534961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are cannabinoids effective for the management of chemotherapy induced nausea and vomiting?
    Morales M; Corsi O; Peña J
    Medwave; 2017 Dec; 17(9):e7119. PubMed ID: 29286355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
    Fonte C; Fatigoni S; Roila F
    Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The magic plant as an antiemetic. Cannabinoids for treatment of nausea and vomiting].
    Kreutz S
    Pharm Unserer Zeit; 2007; 36(5):389-92. PubMed ID: 17722146
    [No Abstract]   [Full Text] [Related]  

  • 13. State of the Art Antiemetic Therapy for Cancer Patients.
    Lau TK; Yip CH; Yeo W
    Curr Oncol Rep; 2016 Jan; 18(1):2. PubMed ID: 26694923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis and treatment of nausea and vomiting associated with cancer or its treatment].
    Simkó C
    Magy Onkol; 2017 Sep; 61(3):247-257. PubMed ID: 28931098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological management of chemotherapy-induced nausea and vomiting in children with cancer.
    Cefalo MG; Ruggiero A; Maurizi P; Attinà G; Arlotta A; Riccardi R
    J Chemother; 2009 Dec; 21(6):605-10. PubMed ID: 20071282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Risk of QTc Prolongation with Antiemetics in the Palliative Care Setting: A Narrative Review.
    Gavioli EM; Guardado N; Haniff F; Deiab N; Vider E
    J Pain Palliat Care Pharmacother; 2021 Jun; 35(2):125-135. PubMed ID: 33974499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Bosnjak SM; Dimitrijevic J; Djordjevic F
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of haloperidol in the management of nausea and vomiting in patients with cancer.
    Hardy JR; O'Shea A; White C; Gilshenan K; Welch L; Douglas C
    J Pain Symptom Manage; 2010 Jul; 40(1):111-6. PubMed ID: 20619214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
    Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
    Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.